Cognitive Abnormality: Clinical Trials

5 trials for Cognitive Abnormality, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 completed, 1 not yet recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 3

Follow Cognitive Abnormality: new trials by email Literature Review of Cognitive Abnormality trials Research Report on Cognitive Abnormality

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of a Decision-Support Tool for Blood Biomarker Testing for Alzheimer's Disease in Primary Care
Shared decision-making support tool - Cognitive Abnormality
Not applicableRecruitingUniversity of Wisconsin, Madison702026-10-072026-10-28
Validity and Reliability of the Turkish Form of the Enjoyment of Physical Activity Scale-8 in Geriatrics With Minimal Cognitive Impairment
Assessments - Geriatric, Elderly
Not yet recruitingIstanbul University - Cerrahpasa1002026-05-152026-05-18
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
Quest AD-Detect blood test - Alzheimer Dementia, Alzheimer Disease
Not applicableRecruitingCovenant Health, US302025-06-102025-10-29
Interventions in Mathematics and Cognitive Skills
Interventions in Mathematics and Cognitive Skills - Experimental, Interventions in Mathematics and Cognitive Skills - Active Comparator - Math Learning Disability, Child Development
Not applicableRecruitingStanford University1802023-05-052026-08-11
Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)
MoCA - Cognitive Impairment, Cognitive Decline
CompletedAndreas Monsch3342016-12-012018-05-31

Narrower conditions

Alzheimer Disease (3)  ·  Cognitive Dysfunction (3)  ·  Cognition Disorders (2)  ·  Lymphoma, Follicular (2)  ·  Behavior (1)  ·  Brain Diseases (1)  ·  Child Behavior (1)  ·  Confusion (1)  ·  Dementia (1)  ·  Developmental Disabilities (1)  ·  Dyscalculia (1)  ·  Learning Disabilities (1)  ·  Motor Activity (1)  ·  Neurobehavioral Manifestations (1)  ·  Orientation, Spatial (1)

Broader conditions

Mental Disorders (5)  ·  Neurocognitive Disorders (5)  ·  Nervous System Diseases (4)  ·  Central Nervous System Diseases (3)  ·  Neurodegenerative Diseases (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Tauopathies (3)  ·  Brain Diseases (2)  ·  Dementia (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)

Interventions

Methods (1)

Sponsors

Andreas Monsch (1)  ·  Covenant Health, US (1)  ·  Istanbul University - Cerrahpasa (1)  ·  Stanford University (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (3)  ·  Turkey (Türkiye) (1)

Top investigators

Alessandra Thomann, MSc (1)  ·  Andreas Monsch, PhD (1)  ·  Fred Ketchum, M.D., Ph.D. (1)  ·  Manfred Berres, PhD (1)  ·  Nicolai Goettel, MD (1)  ·  Raphael Monsch, MD (1)  ·  Samuel Moore, MD (1)

Results publications

PMID 21951520, PMID 34769552

NIH funding

R00AG083131 (1), R01HD059205 (1)